Inflammation, Microbiome and Immunosurveillance
- Research works
- 7 ▼ 61% vs 2013–17
- Citations
- 363 51.6 per fractional work
- Top-10% rate
- 28.6% record average 16.5%
- Open access
- 48% world 28%
Not ranked overall: Inflammation, Microbiome and Immunosurveillance is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which research topics does Inflammation, Microbiome and Immunosurveillance publish most on?
By volume in 2022–2025: Cervical Cancer and HPV Research, Otitis Media and Relapsing Polychondritis, Platelet Disorders and Treatments and Multiple Myeloma Research and Treatments.
- 1 Cervical Cancer and HPV Research Epidemiology 0 works
- 2 Otitis Media and Relapsing Polychondritis Rheumatology 0 works
- 3 Platelet Disorders and Treatments Hematology 0 works
- 4 Multiple Myeloma Research and Treatments Hematology 0 works
- 5 Genital Health and Disease Surgery 0 works
- 6 Hepatitis B Virus Studies Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Inflammation, Microbiome and Immunosurveillance's research output changed?
Output in 2018–2022 was 61% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Orsay
- Hôpital Antoine-Béclère
- Hôpital d'instruction des Armées Percy
- LafargeHolcim (France)
- LivaNova (France)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.